Skip to main content
SpringerLink
Log in

Cirrhosis and hypergammaglobulinemia

  • Editorial
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Feizi T: Immunoglobulins in chronic liver disease. Gut 9:193–198, 1968

    Google Scholar 

  2. Cohen S: γ-Globulin metabolism. Br Med Bull 19:202–206, 1963

    Google Scholar 

  3. Havens WP, Dickensheets J, Bierly JN, Eberhard TP: The half life of I131 labeled normal human gama globulin in patients with hepatic cirrhosis. J Immunol 73:256–258, 1954

    Google Scholar 

  4. Glagov S, Kent G, Popper H: Relation of splenic and lymph node changes to hypergammaglobulinemia in cirrhosis. AMA Arch Pathol 67:9–18, 1959

    Google Scholar 

  5. Triger DR, Wright R: Hypergammaglobulinemia in liver disease. Lancet 1:1494–1496, 1973

    Google Scholar 

  6. Beeson PB, Brannon ES, Warren JV: Observations of the sites of removal of bacteria from the blood in patients with bacterial endocartis. J Exp Med 81:9–18, 1945

    Google Scholar 

  7. Thomas HC, McSween RNM, White RG: Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet 1:1288–1291, 1973

    Google Scholar 

  8. Triger DR, Alp MH, Wright R: Bacterial and dietary antibodies in liver disease. Lancet 1:60–63, 1972

    Google Scholar 

  9. Bjørneboe M, Prytz H, Ørskov F: Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver. Lancet 1:58–60, 1972

    Google Scholar 

  10. Dordal E, Shames T: Pancreatic parenchymal iron in iron loaded rats with portacaval shunts. Fed Proc 25:667, 1976

    Google Scholar 

  11. Triger DR, Kurtz JB, MacCallum FO, Wright R: Raised antibody titres to measles and rubella viruses in chronic active hepatitis. Lancet 1:665–667, 1972

    Google Scholar 

  12. Havens WP, Shaffer JM, Hopke CJ: The production of antibody by patients with chronic hepatic disease. J Immunol 67:347–356, 1951

    Google Scholar 

  13. Bjørnboe M, Jensen KB, Scheibel I, Chr Thomsen Å, Bentzon MW: Tetanus antitoxin production and gamma globulin levels in patients with cirrhosis of the liver. Acta Med Scand 188:541–546, 1970

    Google Scholar 

  14. Cherrick GR, Potheir L, Dufour JJ, Sherlock S: Immunologic response to tetanus toxoid inoculation in patients with hepatic cirrhosis. N Engl J Med 261:340–342, 1959

    Google Scholar 

  15. Tomasi TB: Diseases of the liver. Immun Dis 78:881–892, 1965

    Google Scholar 

  16. Klassen LW, Krakauer RS, Steinberg AD: Selective loss of suppressor cell function in New Zealand mice induced by NTA. J Immunol 119:830–837, 1977

    Google Scholar 

  17. Sagawa A, Abdou NI: Suppressor-cell antibody in systemic lupus erythematosus. J Clin Invest 63:536–539, 1979

    Google Scholar 

  18. Moutsopoulos HM, Boehm-Truitt M, Kassan SS, Chused TM: Demonstration of activation of B-lymphocytes in New Zealand black mice at birth by an immunoradiometric assay for murine IgM. J Immunol 119:1639–1644, 1977

    Google Scholar 

  19. Cohen PL, Ligler FS, Ziff M, Vitetta ES: Increased ratio of surface IgM/surface IgD on spleen cells from NZB mice. Arthritis Rheum 21:551–552, 1978

    Google Scholar 

  20. Steinberg AD, Klassen LW, Budman DR, Williams GW: Loss of brightly staining T cells in active disease. Arthritis Rheum 22:114–122, 1979

    Google Scholar 

  21. Waldman TA, Broder S, Blaese RM, Durm M, Blackburn M, Strober W: Role of suppressor T cells in the pathogenesis of common variable hypogammaglobulinemia. Lancet 2:609–613, 1974

    Google Scholar 

  22. De La Concha EG, Oldham G, Webster ADB, Asheron GL, Platt-Mills TAE: Quantitative measurements of T and B cell functions in ‘variable’ primary hypogammaglobulinaemia: Evidence for a consistent B cell defect. Clin Exp Immunol 27:208–215, 1977

    Google Scholar 

  23. Geha RS, Schneeberger E, Merler E, Rosen FS: Heterogeneity of ‘acquired’ or common variable agammaglovulinemia. N Engl J Med 291:1–6, 1974

    Google Scholar 

  24. Clagett JA, Engel D: Polycolona activation: A form of primitive immunity and its possible role in pathogenesis of inflammatory diseases. Dev Com Immunol 2:235–241, 1978

    Google Scholar 

  25. Goodman GW, Sultzer BM: Encotoxin protein is a mitogen and polyclonal activator of human B lymphocytes. J Exp Med 149:713–723, 1979

    Google Scholar 

  26. Chase MW: Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 61:257–259, 1946

    Google Scholar 

  27. Cantor HM, Dumont AE: Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 215:744–745, 1967

    Google Scholar 

  28. Bastern A, Miller JFAP, Johnson D: T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev 26:130–169, 1975

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Rheumatology-Clinical Immunology Department of Medicine Moffitt Hospital, University of California, 94143, San Francisco, California

    John D. Stobo MD (Investigator of the Howard Hughes Medical Institute)

Authors
  1. John D. Stobo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stobo, J.D. Cirrhosis and hypergammaglobulinemia. Digest Dis Sci 24, 737–740 (1979). https://doi.org/10.1007/BF01317204

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01317204

Search

Navigation